Phase 4 Study Comparing IOP Lowering in OAG or OH in Caucasian or Japanese Subjects C-02-32

Alcon

Status and phase: Terminated; Phase 4

Conditions: Open-angle Glaucoma; Ocular Hypertension

Treatments: Drug: IOP Lowering Medications

Study type: Interventional

Funder types: Industry

Identifiers

NCT00047606

C-02-32

Details and patient eligibility

About

The purpose of this study is to evaluate safety and efficacy of two different IOP lowering medications after six weeks of treatment in Caucasian and Japanese subjects.

Enrollment: 84 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Adults of Caucasian and Japanese Ethnicity

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind